简介
Jan Walewski
Hemato-Oncologist, FMGEMS certified, Professor in Medical Science 2007,
Chair, Department of Lymphoid Malignancies 2010-2023, Consultant in Medical Oncology, Director, Maria Sklodowska-Curie National Research Institute of Oncology 2016-2024. Fellowships at Montefiore Medical Center/Albert Einstein College of Medicine, New York, USA, Cleveland Clinic Cancer Center, Cleveland, USA, St. Bartholomew’s Hospital, London, UK, Visiting Professor, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, USA.
He implemented a method of intensive high-dose methotrexate and immunochemotherapy of Burkitt lymphoma as well as a clinical program of high-dose therapy with hematopoietic cell transplantation at the Department of Lymphoid Malignancies, Oncology Institute in Warsaw. He initiated accession of the Oncology Institute to the European Leukemia Net and the European Mantle Cell Lymphoma Network in 2004, and was a primary investigator of essential clinical studies led within these Networks in Poland. Founder Member of the Polish Lymphoma Research Group and a primary investigator of key prospective clinical trials run by the Group. ESMO Faculty Member for Hematologic Malignancy term 2015-2016. Member of Polish Lymphoma Research Group, Polish Adult Leukemia Group, Polish Society of Oncology, Polish Society of Clinical Oncology, Polish Society of Hematologists and Transfusiologists, American Society of Hematology, American Society of Clinical Oncology, European Society of Medical Oncology, European Blood and Marrow Transplantation Group, EORTC Lymphoma Group, EHA Lymphoma Group, European Lymphoma Institute.
